Home
Login Register
Singapore eDev   

HOT POTENTIAL BIO-TECHS PLAYS

 Post Reply 61-80 of 187
 
gregtan123
    23-Apr-2020 10:26  
Contact    Quote!
Guys, Big News, u know the share swap, E-Development execute price is 0.21 USD (worth 50 million USD). now 0.32 USD which is 50% which means worth US 75 million dollars. Also the increase likely due to insider of DSS know Impact Biomedical Equivir may have had a breakthrough!!! Dyodd!! Im vested. But their whole team is back ny the US Govt and Military!! They have former US military Surgeon-General on their team! #MAGA

0.32  USD  +0.062  (24.31%)
Closed:  22 Apr, 7:59 pm GMT-4 ·   Disclaimer
After hours  0.34  +0.023  (7.26%)
 
 
Wind22i
    23-Apr-2020 10:12  
Contact    Quote!
Clearbridge and biolidics both has jumped like ~300%

So Sing Edev is only up ~50%..

All 3 is in top 10 volume covid play
 
 
Wind22i
    23-Apr-2020 10:08  
Contact    Quote!
Now i believs is not the highest price yet , if u benchmark against the more illustrious biolidics and clearbridge
 

 
ruready
    23-Apr-2020 10:03  
Contact    Quote!
Bb collecting sweat n sweet, roti prata, he collect very vert long flip flip until trader don't know to go home, still early stage
 
 
wolverine23
    23-Apr-2020 09:47  
Contact    Quote!
attempt to cross 68.

Wind22i      ( Date: 23-Apr-2020 09:42) Posted:

Can u predict today closing price

 
 
NL0261
    23-Apr-2020 09:46  
Contact    Quote!
by the way, fr. construction divert into medical huh? 🤔

Wind22i      ( Date: 23-Apr-2020 09:01) Posted:

So will it be the next biolidics?

 

 
Wind22i
    23-Apr-2020 09:42  
Contact    Quote!
Can u predict today closing price
 
 
wolverine23
    23-Apr-2020 09:39  
Contact    Quote!
internet bull 2000 = medical bull 2020

Wind22i      ( Date: 23-Apr-2020 09:36) Posted:

Now 4.4cents ... u predict 30 cents?

 
 
Wind22i
    23-Apr-2020 09:36  
Contact    Quote!
Now 4.4cents ... u predict 30 cents?
 
 
wolverine23
    23-Apr-2020 09:32  
Contact    Quote!
I predict Medtecs: $0.6 Bio: $1.38 Clearbridge: $1 Trendlines: $0.8 Sed: $0.3 UG: $0.6 OEL: $0.1
 

 
SmallSmall
    23-Apr-2020 09:27  
Contact    Quote!
 
 
Wind22i
    23-Apr-2020 09:27  
Contact    Quote!
John lennon.. anyway, the share price is sort of telling ppl "hey something big coming"..
 
 
wolverine23
    23-Apr-2020 09:26  
Contact    Quote!
hahahaaaa
 
 
commando
    23-Apr-2020 09:25  
Contact    Quote!
Just imagine...gd to dream

Wind22i      ( Date: 23-Apr-2020 09:15) Posted:

So imagine what if this vaccine effectiveness proven tested and marketted , ie. It is use to fight covid, then the edev will not be at this price anymore ...

 
 
Wind22i
    23-Apr-2020 09:24  
Contact    Quote!
Now they was acquired or jv with dss via share swap.. so dss may have the funds...

ken777      ( Date: 23-Apr-2020 09:22) Posted:

  I think they dont have the funding to create vaccine. Not sure else BB would already fry this up. So much easier 

 

 
ken777
    23-Apr-2020 09:22  
Contact    Quote!
  I think they dont have the funding to create vaccine. Not sure else BB would already fry this up. So much easier 
 
 
Wind22i
    23-Apr-2020 09:20  
Contact    Quote!
There could be an update news coming right? Last update was more than a month ago..
It will fly like biolidics or what not if the news is sounds like progress path to commertialization of that vaccine..

Cld it be like biolidics? Its your call.. good luck
 
 
Wind22i
    23-Apr-2020 09:15  
Contact    Quote!
So imagine what if this vaccine effectiveness proven tested and marketted , ie. It is use to fight covid, then the edev will not be at this price anymore ...
 
 
Wind22i
    23-Apr-2020 09:08  
Contact    Quote!
Seems like good news coming ? Huat !
 
 
SmallSmall
    23-Apr-2020 09:05  
Contact    Quote!

Last month' s News ->

SINGAPORE,  Mar 18, 2020  - (ACN Newswire) - - SGX-listed  Singapore eDevelopment Ltd  (SeD SGX:40V) has announced that its wholly-owned  U.S.  biomedical subsidiary  Impact BioMedical, Inc.  has through its scientific research partner  GRDG Sciences, LLC. conducted molecular docking studies utilizing advanced computational models, indicating that its Linebacker and Equivir compounds successfully inhibit infection by SARS-CoV-2, the virus responsible for the COVID-19 outbreak. The results indicate that the two compounds block 3 integral viral mechanisms for SARS-CoV-2 replication and infection: the viral spike interaction point, helicase, and protease.

Equivir and Linebacker are undergoing accelerated testing against the SARS-CoV-2 virus and data is expected to confirm efficacy based on previous work against other coronaviruses such as SARS and MERS. This research is part of a program conducted by GRDG to adhere to the principles and initiatives established by Project Bioshield and the  Biomedical Advanced Research and Development Authority  (BARDA) directives from the  U.S. Department of Health and Human Services  (HHS).

Wind22i      ( Date: 23-Apr-2020 09:01) Posted:

So will it be the next biolidics?

 
Important: Please read our Terms and Conditions and Privacy Policy .